Brean Murray Carret & Co Maintains Hold Rating on Hologic

A report from Brean Murray Carret & Co reiterates its Hold rating on Hologic HOLX. The report states, “we do not anticipate FQ4 earning sor F12 guidance to be materially below current views. We expect the early update on Tomo adoption, to be at least on track with management “expectations” and may represent some positive “surprise” given what we perceive as low expectations." HOLX closed yesterday at $16.36.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorNewsGuidanceReiterationAnalyst RatingsBrean Murray Carret & Company
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!